Retatrutide API – Lyophilized Powder (≥98% Purity)
Verified Supplier
CHP00230
High-purity Retatrutide API in lyophilized powder form, ≥98% purity. Supplied strictly for laboratory and research use.
Available in
Hong Kong
Supplier based in
Hong Kong
- All products listed on Conect2health are verified and approved to help ensure a reliable purchasing experience.
- Conect2health assists you in connecting with suppliers for product enquiries and purchasing requirements.
- Need help with a supplier, product information, or any other related query? Our team is here to support you throughout the process.
Hong Kong Dengyue Pharmaceutical Limited
Product Description
Retatrutide API is offered as a lyophilized (freeze-dried) powder with a verified purity of ≥98%, suitable for in-vitro and pre-clinical research applications. Retatrutide is a triple agonist studied for its activity at GLP-1, GIP, and glucagon receptors, making it a compound of interest in metabolic and endocrinology-related research.
Shipping & Packaging
Lead time
N/A
Payment terms
N/A
Port of loading
N/A
Target Regions
Hong Kong
